BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20667585)

  • 1. The devastating consequences of thrombosis of systemico pulmonary shunts and the blind administration of aspirin.
    d'Udekem Y
    Thromb Res; 2010 Sep; 126(3):163. PubMed ID: 20667585
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin resistance following pediatric cardiac surgery.
    Cholette JM; Mamikonian L; Alfieris GM; Blumberg N; Lerner NB
    Thromb Res; 2010 Sep; 126(3):200-6. PubMed ID: 20550971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin unresponsiveness predicts thrombosis in high-risk pediatric patients after cardiac surgery.
    Emani S; Trainor B; Zurakowski D; Baird CW; Fynn-Thompson FE; Pigula FA; Emani SM
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):810-4; discussion 814-6. PubMed ID: 25129584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the best practice patterns for the neonatal systemic-to-pulmonary artery shunt procedure.
    Heidari-Bateni G; Norouzi S; Hall M; Brar A; Eghtesady P
    J Thorac Cardiovasc Surg; 2014 Mar; 147(3):869-873.e3. PubMed ID: 24332191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update.
    Cuisset T; Valgimigli M; Mudra H; Muller O; Wijns W; Huber K
    EuroIntervention; 2010 May; 6(1):39-45. PubMed ID: 20542796
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet Inhibition in Shunted Infants on Aspirin at Short and Midterm Follow-Up.
    Truong DT; Johnson JT; Bailly DK; Clawson JR; Sheng X; Burch PT; Witte MK; LuAnn Minich L
    Pediatr Cardiol; 2017 Feb; 38(2):401-409. PubMed ID: 28039526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resistance to desaggregants: causes, clinical implication, methods of diagnosis and correction].
    Kremneva LV; Shalaev SV
    Ter Arkh; 2008; 80(12):89-95. PubMed ID: 19227916
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G; Segalés E; Salas E; Badimon L
    Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet testing to guide aspirin dose adjustment in pediatric patients after cardiac surgery.
    Emani S; Zurakowski D; Mulone M; DiNardo JA; Trenor CC; Emani SM
    J Thorac Cardiovasc Surg; 2017 Nov; 154(5):1723-1730. PubMed ID: 28712586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombosis in congenital heart disease.
    Khairy P
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1579-82. PubMed ID: 24215186
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring of acetyl salicylic acid-induced platelet inhibition with impedance aggregometry in children with systemic-to-pulmonary shunts.
    Romlin BS; Wåhlander H; Strömvall-Larsson E; Synnergren M; Baghaei F; Jeppsson A
    Cardiol Young; 2013 Apr; 23(2):225-32. PubMed ID: 22691184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recommendations for peri-procedural thrombocyte aggregation inhibition].
    Sauer H; Leschke M
    Dtsch Med Wochenschr; 2006 Feb; 131(8):400-2. PubMed ID: 16479474
    [No Abstract]   [Full Text] [Related]  

  • 13. The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid.
    Clappers N; van Oijen MG; Sundaresan S; Brouwer MA; Te Morsche RH; Keuper W; Peters WH; Drenth JP; Verheugt FW
    Thromb Haemost; 2008 Jul; 100(1):70-5. PubMed ID: 18612540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin-resistant platelet aggregation in a cohort of patients with coronary heart disease.
    Pamukcu B; Oflaz H; Onur I; Oncul A; Umman B; Koylan N; Bugra Z; Meric M; Nisanci Y
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):461-5. PubMed ID: 17581321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.
    Zimmermann N; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin as antiplatelet agent in diabetes. PROS-.
    Davì G; Santilli F
    Eur J Intern Med; 2010 Jun; 21(3):149-53. PubMed ID: 20493412
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence-based management of patients undergoing PCI: stent controversies.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2010 Mar; 75 Suppl 1():S39-42. PubMed ID: 20333706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suspected incidence of aspirin resistance.
    Okeahialiam BN; Ikeme AC
    West Afr J Med; 2010; 29(2):129. PubMed ID: 20544642
    [No Abstract]   [Full Text] [Related]  

  • 19. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
    Wallén H; Agren A; Nekludov M
    Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiplatelet therapy: aspirin.
    Steinhubl SR
    J Invasive Cardiol; 2003 Mar; 15 Suppl B():11B-16B; discussion 16B. PubMed ID: 12724581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.